Sophie Glatt, MD; Gregor B. E. Jemec, MD; Seth Forman, MD; et al.
open access
JAMA Dermatol. 2021;157(11):1279-1288. doi:10.1001/jamadermatol.2021.2905
This randomized clinical trial assesses whether bimekizumab is efficacious and safe when used to treat patients with hidradenitis suppurativa.
Annabel Maruani, MD, PhD; Elsa Tavernier, PhD; Olivia Boccara, MD; et al.
free access
JAMA Dermatol. 2021;157(11):1289-1298. doi:10.1001/jamadermatol.2021.3459
This randomized clinical trial assesses the efficacy and safety of sirolimus among children with slow-flow vascular malformations to better delineate the indications for treatment.
Surya A. Veerabagu, BA; Brian Cheng, BS; Sonia Wang, BS; et al.
free access
JAMA Dermatol. 2021;157(11):1299-1305. doi:10.1001/jamadermatol.2021.3468
This cross-sectional study characterizes the frequency and changes over time (2009-2020) of opioid prescriptions following Mohs micrographic surgery.
Kristina M. Harris, PhD; Dawn E. Smilek, MD, PhD; Margie Byron, MStat; et al.
open access
JAMA Dermatol. 2021;157(11):1306-1315. doi:10.1001/jamadermatol.2021.3492
This parallel-design, double-blind randomized clinical trial evaluates whether abatacept could prevent psoriasis relapse after discontinuation of ustekinumab treatment in adults with plaque psoriasis.
Surapon Nochaiwong, PharmD; Mati Chuamanochan, MD; Chidchanok Ruengorn, PhD; et al.
free access
JAMA Dermatol. 2021;157(11):1316-1327. doi:10.1001/jamadermatol.2021.3237
This network meta-analysis examines the effects of H1 antihistamines reported in randomized clinical trials for treatment in patients with chronic spontaneous urticaria.
Alyson A. Endicott, MD; Sarah L. Chamlin, MD; Beth A. Drolet, MD; et al.
free access
JAMA Dermatol. 2021;157(11):1328-1334. doi:10.1001/jamadermatol.2021.3479
This cohort study aims to refine previous maps defining the distribution of facial segment hemangiomas and determine whether patterns of indeterminate hemangiomas are related to their segmental counterparts.
Bevin Bhoyrul, MBBS; Leila Asfour, MBChB; Gerhard Lutz, PhD; et al.
free access
JAMA Dermatol. 2021;157(11):1335-1342. doi:10.1001/jamadermatol.2021.3676
This case series analyzes the clinicopathologic characteristics and response to treatment of patients with persistent chemotherapy-induced alopecia after chemotherapy for breast cancer.
Julie D. R. Reimann, MD, PhD; Sean P. Moynihan, MS; Thomas D. Horn, MD, MBA
free access
JAMA Dermatol. 2021;157(11):1343-1348. doi:10.1001/jamadermatol.2021.3892
This quality improvement study examines the need for specific vs full-panel antibody testing in patients with skin diseases.